Funds holding KAZIA THERAPEUTICS LTD
ISIN US48669G3039 · Australia
- Fund holders
- 2
- Of which ETFs
- 1 1 other fund
- Value held
- 44.1K $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| ActivePassive International Equity ETF Trust for Professional Managers | 3,251 | 41.5K $ | 0.00 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 196 | 2.5K $ | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ActivePassive International Equity ETF Trust for Professional Managers | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | +1 | 3,447 | +1,658.7 % |
| 2026Q2 | 1 | 0 | 196 | 0.0 % |
| 2026Q1 | 1 | 0 | 196 | 0.0 % |
| 2025Q4 | 1 | 0 | 196 | 0.0 % |
| 2025Q3 | 1 | 196 |
Institutional managers
23 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Bleichroeder LP | 400,000 | 3M $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 345,179 | 2.6M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 200,000 | 1.5M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 193,114 | 1.4M $ | as of Mar 31, 2026 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 142,469 | 1.1M $ | as of Mar 31, 2026 |
| Velan Capital Investment Management LP | 135,315 | 1M $ | as of Mar 31, 2026 |
| Dauntless Investment Group, LLC | 79,832 | 594K $ | as of Mar 31, 2026 |
| Sequoia Financial Advisors, LLC | 60,000 | 446.4K $ | as of Mar 31, 2026 |
| Westside Investment Management, Inc. | 50,425 | 375.2K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 34,340 | 255K $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 23,999 | 178.6K $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 15,749 | 117.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 13,934 | 103.7K $ | as of Mar 31, 2026 |
| Rockefeller Capital Management L.P. | 12,700 | 94.5K $ | as of Mar 31, 2026 |
| Laird Norton Wetherby Trust Company, LLC | 12,400 | 92.3K $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 10,608 | 78.9K $ | as of Mar 31, 2026 |
| FNY Investment Advisers, LLC | 10,000 | 74 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 8,744 | 65K $ | as of Mar 31, 2026 |
| GAMMA Investing LLC | 1,568 | 11.7K $ | as of Mar 31, 2026 |
| RHUMBLINE ADVISERS | 1,402 | 10.4K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 1,081 | 8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,000 | 7.4K $ | as of Mar 31, 2026 |
| Allworth Financial LP | 1 | 8 $ | as of Mar 31, 2026 |
Declared shareholders of KAZIA THERAPEUTICS LTD
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Ikarian Capital, LLC and 1 other | 4.90 % | 575,778 | as of Jun 30, 2026 · SCHEDULE 13G |
| Lynwood Capital Management Inc. and 2 others | 4.60 % | 264,980,500 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding KAZIA THERAPEUTICS LTD". https://titelia.com/en/stocks/kazia-therapeutics-ltd-US48669G3039